Access cutting-edge cancer treatment through this clinical trial at a research site in Pittsburgh. Study-provided care at no cost to qualified participants.
Access cancer specialists in Pittsburgh at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cancer treatment provided free
This is a 2-part, phase 1/2, open-label, multicenter study designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, pharmacogenomics, and efficacy of CYC140 administered orally daily. This study consists of Phase 1 and Phase 2 components in subjects with advanced solid tumors and lymphoma who have progressed despite having standard therapy or for which no standard therapy exists.
Sponsor: Cyclacel Pharmaceuticals, Inc.
Check if you qualify for this cancer clinical trial in Pittsburgh, PA
If you're searching for cancer treatment options in Pittsburgh, PA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Pittsburgh research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.